Appia Bio

Company Information

Founded Year
Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).

Get Contact Info for All Employees

Emily Lowe

Senior Director

Edmund Kim

Chief Operating Officer

Qi Wei

SVP, Head of TechOps

David Morse

VP Head of Quality at Appia Bio

Start with AroundDeal For Free!

Instant access. Cancel anytime

Sign Up to View Appia Bio’s Top Employees

Instant access. Cancel anytime

Frequently Asked Questions Regarding Appia Bio

What is Appia Bio website?